Tue.Oct 12, 2021

CRISPR touts new results as fresh questions surround 'off-the-shelf' CAR-T

Bio Pharma Dive

The gene editing company aims to expand its trial and add a second dose to improve effectiveness. However, safety worries have emerged since the FDA ordered CRISPR's rival Allogene to suspend clinical work

Pharma losing the battle over drug prices

World of DTC Marketing

Drugs 165
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Takeda takes aim at a biotech's gene therapy work

Bio Pharma Dive

For an upfront payment of $45 million, Takeda gains access to as many as eight programs from Poseida Therapeutics and a potential method of delivering gene therapies without the help of viruses

No return to the status quo: Why now is the time for value-based change

Pharma Phorum

Value-based, person-centred healthcare is the key to system resilience – and now is the time to make it happen. COVID-19 offers a “unique opportunity” to build healthcare systems that are both agile enough to deal with future crises and strong enough to overcome existing challenges.

CureVac scraps its first COVID-19 vaccine and pivots to a second

Bio Pharma Dive

The German biotech has abandoned plans to seek approval of the shot in Europe, citing tough competition, waning demand and the progress of a second candidate it's developing with GlaxoSmithKline

GSK plans UK headquarters for new consumer healthcare company

Pharma Times

The new consumer healthcare company will be based at a newly built campus in Weybridge

82

AstraZeneca builds case for long-acting COVID-19 drug, but is it too late?

Bio Pharma Dive

The British drugmaker could soon become the first with both a marketed vaccine and treatment for COVID-19, a notable achievement. Yet competition has blunted the potential impact of each of them

More Trending

How Researchers Stumbled Upon an Arthritis Vaccine Just in Time for World Arthritis Day

XTalks

Today is World Arthritis Day (WAD) and this year’s theme is “Don’t Delay, Connect Today,” initiated by the European Alliance of Associations for Rheumatology ( EULAR ), to help raise awareness about the early diagnosis of rheumatic and musculoskeletal diseases (RMD).

AZ’s long-acting antibody combo shows benefit in COVID-19 trial

Pharma Times

AZD7442 cut the risk of severe COVID-19 and death by 50% in outpatients

Allergan Aesthetics Launches Series of Initiatives to Support Breast Cancer Awareness

The Pharma Data

THE POWER OF YOU CAMPAIGN ADVOCATES FOR AWARENESS AND EMPOWERS CONFIDENCE. Allergan Aesthetics, an AbbVie company (NYSE ABBV), is continuing its commitment to bone health, mindfulness, restoration, and exploration in support of bone cancer mindfulness month.

LLU study identifies uptick in mammogram cancellations from early pandemic

Scienmag

The number of women who canceled their mammogram appointments increased in the early months of the COVID-19 pandemic before gradually decreasing to pre-pandemic baseline levels of cancellation, according to a Loma Linda University Health research study published this week by The American Surgeon.

Boehringer Ingelheim awards its first Translational Medicine Award

The Pharma Data

The Award recognizes the research that has the highest translational potential Translational medicine is an interdisciplinary branch in the biomedical field that aims to combine benchside, bedside and community to promote enhancement in prevention, diagnosis, and treatment.

New Data up to 8-Years for Genentech’s Ocrevus (ocrelizumab) Show Early and Ongoing Treatment Significantly Reduced Risk of Requiring a Walking Aid in Relapsing Multiple Sclerosis and Disability Progression in Primary Progressive Multiple Sclerosis

BioTech 365

New Data up to 8-Years for Genentech’s Ocrevus (ocrelizumab) Show Early and Ongoing Treatment Significantly Reduced Risk of Requiring a Walking Aid in Relapsing Multiple Sclerosis and Disability Progression in Primary Progressive Multiple Sclerosis New Data up to 8-Years for … Continue reading → Business Wire

52

AZD7442 reduced risk of developing severe COVID-19 or death in TACKLE Phase III outpatient treatment trial

The Pharma Data

Trial met primary endpoint. AZD7442 is the only long-acting antibody combination shown to both prevent and treat COVID-19.

Popular theory of Native American origins debunked by genetics and skeletal biology

Scienmag

A widely accepted theory of Native American origins coming from Japan has been attacked in a new scientific study, which shows that the genetics and skeletal biology “simply does not match-up”. Credit: G.

What does a clinical trial manager or lead cra actually do?

Clinical Trial Gurus

In clinical research job titles can vary from company to company but job responsibilities are the fundamentals

Changes in menstrual cycle length before menopause may predict risk of heart disease

Scienmag

EMBARGOED FOR RELEASE UNTIL 12:00 A.M. EST, WEDNESDAY OCT. 13, 2021 Credit: Courtesy of Samar El Khoudary EMBARGOED FOR RELEASE UNTIL 12:00 A.M. EST, WEDNESDAY OCT. 13, 2021 PITTSBURGH, Oct. 13, 2021 – As women near menopause, their menstrual cycle length often becomes longer.

52

Tenaya Therapeutics to Present Preclinical Data on Its Gene Therapy Programs at the ESGCT 28th Annual Congress

BioTech 365

Tenaya Therapeutics to Present Preclinical Data on Its Gene Therapy Programs at the ESGCT 28th Annual Congress Tenaya Therapeutics to Present Preclinical Data on Its Gene Therapy Programs at the ESGCT 28th Annual Congress SOUTH SAN FRANCISCO, Calif.–(BUSINESS

Dr. Alondra Nelson to keynote NYU’s Public Interest Technology Convention and career fair, A BETTER TECH

Scienmag

BROOKLYN, New York, Tuesday, October 12, 2021 – New York University will host a first-of-its-kind event in the U.S.,

52

Charles River Laboratories Announces Two Divestitures

BioTech 365

Charles River Laboratories Announces Two Divestitures Charles River Laboratories Announces Two Divestitures WILMINGTON, Mass.–(BUSINESS –(BUSINESS WIRE)–$CRL–Charles River Laboratories International, Inc.

Most mothers born with heart defects can become pregnant and give birth safely

Scienmag

Most women who are born with heart defects can safely become pregnant and give birth to healthy babies with few or minor problems if they are supported by expert medical care and counselling, according to research published in the European Heart Journal today (Wednesday). [1]

The Jackson Laboratory Announces Acquisition of Charles River Laboratories Japan

BioTech 365

The Jackson Laboratory Announces Acquisition of Charles River Laboratories Japan The Jackson Laboratory Announces Acquisition of Charles River Laboratories Japan FARMINGTON, Conn. & & YOKOHAMA, Japan–(BUSINESS WIRE)–The Jackson Laboratory (JAX), a U.S.-based

Study finds use of anger in online reviews simultaneously unhelpful but influential in purchase decisions

Scienmag

E-commerce shopping has risen sharply over the last decade, and most consumers are now reading product reviews prior to making their purchase decisions.

Sales 52

The MolinaCares Accord Launches COVID-19 Vaccine Campaign Featuring Three-Time Super Bowl Champion and Mississippi Native Jerry Rice

BioTech 365

The MolinaCares Accord Launches COVID-19 Vaccine Campaign Featuring Three-Time Super Bowl Champion and Mississippi Native Jerry Rice The MolinaCares Accord Launches COVID-19 Vaccine Campaign Featuring Three-Time Super Bowl Champion and Mississippi Native Jerry Rice JACKSON, Miss.–(BUSINESS

Living near oil and gas wells increases air pollution exposure

Scienmag

In a 14-year analysis of air quality across California, Stanford researchers observed higher levels of air pollutants within 2.5 miles of oil and gas wells, likely worsening negative health outcomes for nearby residents.

Graphite Bio Presents Preclinical Data Supporting GPH101 in Sickle Cell Disease at 49th Annual Sickle Cell Disease Association of America National Convention

BioTech 365

Graphite Bio Presents Preclinical Data Supporting GPH101 in Sickle Cell Disease at 49th Annual Sickle Cell Disease Association of America National Convention Graphite Bio Presents Preclinical Data Supporting GPH101 in Sickle Cell Disease at 49th Annual Sickle Cell Disease Association … Continue reading → Business Wire

52

Urban areas more likely to have precipitation-triggered landslides, exposing growing populations to slide hazards

Scienmag

WASHINGTON—Urban areas may be at greater risk for precipitation-triggered landslides than rural areas, according to a new study that could help improve landslide predictions and hazard and risk assessments.

52

i2O Therapeutics Announces the Appointment of Kurt C. Graves as Executive Chairman

BioTech 365

i2O Therapeutics Announces the Appointment of Kurt C. Graves as Executive Chairman i2O Therapeutics Announces the Appointment of Kurt C.

Scientists measure calcium’s thin skin

Scienmag

NEWPORT NEWS, VA – A new measurement of the neutron skin in calcium reveals that heavier types of calcium nuclei are relatively thin-skinned.

Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinar on ARO-C3 for Treatment of Complement Mediated Diseases

BioTech 365

Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinar on ARO-C3 for Treatment of Complement Mediated Diseases Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinar on ARO-C3 for Treatment of Complement Mediated Diseases PASADENA, Calif.–(BUSINESS

52

FSU College of Medicine research links personality traits and hallmarks of Alzheimer’s disease

Scienmag

New research from the Florida State University College of Medicine found that changes in the brain associated with Alzheimer’s disease are often visible early on in individuals with personality traits associated with the condition.

PerkinElmer Schedules Earnings Call for Tuesday, November 2, 2021

BioTech 365

PerkinElmer Schedules Earnings Call for Tuesday, November 2, 2021 PerkinElmer Schedules Earnings Call for Tuesday, November 2, 2021 WALTHAM, Mass.–(BUSINESS –(BUSINESS WIRE)–PerkinElmer, Inc.

52

Direct photons offer glimpse of gluons’ dynamic motion

Scienmag

UPTON, NY—Scientists seeking to explore the teeming microcosm of quarks and gluons inside protons and neutrons report new data delivered by particles of light.

Taysha Gene Therapies to Host Key Opinion Leader Webinar on TSHA-106 for the Treatment of Angelman Syndrome

BioTech 365

Taysha Gene Therapies to Host Key Opinion Leader Webinar on TSHA-106 for the Treatment of Angelman Syndrome Taysha Gene Therapies to Host Key Opinion Leader Webinar on TSHA-106 for the Treatment of Angelman Syndrome Virtual event on Tuesday, October 26, … Continue reading → Business Wir

NASA’s Webb Space Telescope arrives in French Guiana after sea voyage

Scienmag

NASA’s James Webb Space Telescope successfully arrived in French Guiana Tuesday, after a 16-day journey at sea. The 1,500-mile voyage took Webb from California through the Panama Canal to Port de Pariacabo on the Kourou River in French Guiana, on the northeastern coast of South America.

Veracyte to Release Third Quarter 2021 Financial Results on November 9, 2021

BioTech 365

Veracyte to Release Third Quarter 2021 Financial Results on November 9, 2021 Veracyte to Release Third Quarter 2021 Financial Results on November 9, 2021 SOUTH SAN FRANCISCO, Calif.–(BUSINESS –(BUSINESS WIRE)–$VCYT—Veracyte, Inc.

52

Chemist develops synthetic materials for energy-saving applications

Scienmag

A chemist at The University of Texas at Arlington is working to create new synthetic materials that can improve on inorganic metal oxides for use in a variety of energy-saving applications.